Literature DB >> 30168197

AggScore: Prediction of aggregation-prone regions in proteins based on the distribution of surface patches.

Kannan Sankar1, Stanley R Krystek2, Stephen M Carl3, Tyler Day1, Johannes K X Maier1.   

Abstract

Protein aggregation is a phenomenon that has attracted considerable attention within the pharmaceutical industry from both a developability standpoint (to ensure stability of protein formulations) and from a research perspective for neurodegenerative diseases. Experimental identification of aggregation behavior in proteins can be expensive; and hence, the development of accurate computational approaches is crucial. The existing methods for predicting protein aggregation rely mostly on the primary sequence and are typically trained on amyloid-like proteins. However, the training bias toward beta amyloid peptides may worsen prediction accuracy of such models when applied to larger protein systems. Here, we present a novel algorithm to identify aggregation-prone regions in proteins termed "AggScore" that is based entirely on three-dimensional structure input. The method uses the distribution of hydrophobic and electrostatic patches on the surface of the protein, factoring in the intensity and relative orientation of the respective surface patches into an aggregation propensity function that has been trained on a benchmark set of 31 adnectin proteins. AggScore can accurately identify aggregation-prone regions in several well-studied proteins and also reliably predict changes in aggregation behavior upon residue mutation. The method is agnostic to an amyloid-specific aggregation context and thus may be applied to globular proteins, small peptides and antibodies.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  adnectin; aggregation propensity; aggregation score; amyloid beta; antibody; electrostatic patches; hydrophobic patches; protein aggregation

Mesh:

Substances:

Year:  2018        PMID: 30168197     DOI: 10.1002/prot.25594

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  21 in total

1.  Bioinformatics Methods in Predicting Amyloid Propensity of Peptides and Proteins.

Authors:  Małgorzata Kotulska; Jakub W Wojciechowski
Journal:  Methods Mol Biol       Date:  2022

2.  Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment.

Authors:  Christopher Negron; Joyce Fang; Michael J McPherson; W Blaine Stine; Andrew J McCluskey
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 3.  Protein aggregation: in silico algorithms and applications.

Authors:  R Prabakaran; Puneet Rawat; A Mary Thangakani; Sandeep Kumar; M Michael Gromiha
Journal:  Biophys Rev       Date:  2021-01-17

Review 4.  Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.

Authors:  Rahul Khetan; Robin Curtis; Charlotte M Deane; Johannes Thorling Hadsund; Uddipan Kar; Konrad Krawczyk; Daisuke Kuroda; Sarah A Robinson; Pietro Sormanni; Kouhei Tsumoto; Jim Warwicker; Andrew C R Martin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

5.  Structure-based machine-guided mapping of amyloid sequence space reveals uncharted sequence clusters with higher solubilities.

Authors:  Nikolaos Louros; Gabriele Orlando; Matthias De Vleeschouwer; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

6.  An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation.

Authors:  Michelle S Miller; Jacqueline Douglass; Michael S Hwang; Andrew D Skora; Michael Murphy; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Shibin Zhou; Sandra B Gabelli
Journal:  J Biol Chem       Date:  2019-11-05       Impact factor: 5.157

7.  Single variable domains from the T cell receptor β chain function as mono- and bifunctional CARs and TCRs.

Authors:  Julyun Oh; Dora Toledo Warshaviak; Mikayel Mkrtichyan; Melanie Lisette Munguia; Abby Lin; Falene Chai; Craig Pigott; Jaspal Kang; Michael Gallo; Alexander Kamb
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

8.  WALTZ-DB 2.0: an updated database containing structural information of experimentally determined amyloid-forming peptides.

Authors:  Nikolaos Louros; Katerina Konstantoulea; Matthias De Vleeschouwer; Meine Ramakers; Joost Schymkowitz; Frederic Rousseau
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

Review 9.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

10.  Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies.

Authors:  Boris Grinshpun; Nels Thorsteinson; Joao Ns Pereira; Friedrich Rippmann; David Nannemann; Vanita D Sood; Yves Fomekong Nanfack
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.